In this study, we excluded the male and female-specific tumor markers (β-HCG, PSA, and free-PSA) and HGH, and only retained AFP, CEA, CA125, CA153, CA199, CA242, FER, and NSE. The gene discussed is ENO2; the disease is neoplasm.